1
|
Elia E, Bruno F, Crimi G, Wańha W, Leonardi S, Mauro M, Raposeiras Roubin S, Fabris E, Giannino G, Mancone M, Severino P, Truffa A, De Filippo O, Huczek Z, Mazurek M, Gaibazzi N, Ielasi A, Cortese B, Borin A, Núñez-Gil IJ, Marengo G, Melis D, Ugo F, Bianco M, Barbieri L, Marchini F, Desperak P, Morici N, Scaglione M, Gąsior M, Gallone G, Lopiano C, Stefanini G, Campo G, Wojakowski W, Abu-Assi E, Sinagra G, de Ferrari GM, Porto I, D'Ascenzo F. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry. Int J Cardiol 2024; 397:131622. [PMID: 38061607 DOI: 10.1016/j.ijcard.2023.131622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Revised: 11/10/2023] [Accepted: 11/27/2023] [Indexed: 12/17/2023]
Abstract
BACKGROUND Impact of gender on heart remodeling after acute coronary syndrome (ACS) and consequently on development of heart failure (HF) remains to be elucidated. METHODS CORALYS is a multicenter, retrospective, observational registry enrolling consecutive patients admitted for ACS and treated with percutaneous coronary intervention. HF hospitalization was the primary endpoint while all-cause mortality and the composite endpoint of incidence of first HF hospitalization and cardiovascular mortality were the secondary ones. RESULTS Among 14,699 patients enrolled in CORALYS registry, 4578 (31%) were women and 10,121 (69%) males. Women were older, had more frequently hypertension and diabetes and less frequently smoking habit. History of myocardial infarction (MI), STEMI at admission and multivessel disease were less common in women. After median follow up of 2.9 ± 1.8 years, women had higher incidence of primary and secondary endpoints and female sex was an independent predictor of HF hospitalization (HR 1.26;1.05-1.50; p = 0.011) and cardiovascular death/HF hospitalization (HR 1.18;1.02-1.37; p = 0.022). At multivariable analysis women and men share as predictors of HF diabetes, history of cancer, chronic kidney disease, atrial fibrillation, complete revascularization and left ventricular ejection fraction. Chronic obstructive pulmonary disease (HR 2.34;1.70-3.22, p < 0.001) and diuretics treatment (HR 1.61;1.27-2.04, p < 0.001) were predictor of HF in men, while history of previous MI (HR 1.46;1.08-1.97, p = 0.015) and treatment with inhibitors of renin-angiotensin system (HR 0.69;0,49-0.96 all 95% CI, p = 0.030) in women. CONCLUSIONS Women are at increased risk of HF after ACS and gender seems to be an outcome-modifier of the relationship between a variable and primary outcome.
Collapse
Affiliation(s)
- Edoardo Elia
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy; DICATOV-Cardiothoracic and Vascular Department, San Martino Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy
| | - Francesco Bruno
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy.
| | - Gabriele Crimi
- DICATOV-Cardiothoracic and Vascular Department, San Martino Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy
| | - Wojciech Wańha
- 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
| | - Sergio Leonardi
- Coronary Care Unit, Fondazione IRCCS Policlinico San Matteo, Italy
| | - Mattia Mauro
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | | | - Enrico Fabris
- Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | - Giuseppe Giannino
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | - Massimo Mancone
- Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Rome, Italy
| | - Paolo Severino
- Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Rome, Italy
| | | | - Ovidio De Filippo
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | - Zenon Huczek
- 1st Department of Cardiology, Medical University of Warsaw, Warszawa, Poland
| | - Maciej Mazurek
- 1st Department of Cardiology, Medical University of Warsaw, Warszawa, Poland
| | - Nicola Gaibazzi
- Cardiology Department, Parma University Hospital, Parma, Italy
| | - Alfonso Ielasi
- U.O. di Cardiologia Clinica ed Interventistica, Istituto Clinico Sant'Ambrogio, Milan, Italy
| | - Bernardo Cortese
- Cardiovascular Research Team, San Carlo Clinic, Milano, Italy; Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy
| | - Andrea Borin
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | - Iván J Núñez-Gil
- Cardiovascular Institute, Hospital Clinico San Carlos, Madrid, Spain
| | - Giorgio Marengo
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | - Daniele Melis
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | - Fabrizio Ugo
- Department of Cardiology, Sant'Andrea Hospital, Vercelli, Italy
| | - Matteo Bianco
- Division of Cardiology, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy
| | - Lucia Barbieri
- Division of Cardiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy
| | - Federico Marchini
- Cardiovascular Institute, Azienda Ospedaliero Universitaria di Ferrara, Cona (FE), Italy
| | - Piotr Desperak
- 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
| | - Nuccia Morici
- IRCCS S. Maria Nascente-Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy
| | - Marco Scaglione
- Division of Cardiology, Ospedale Cardinal G. Massaia, Asti, Italy
| | - Mariusz Gąsior
- 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
| | - Guglielmo Gallone
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | - Clara Lopiano
- IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy
| | | | - Gianluca Campo
- Cardiovascular Institute, Azienda Ospedaliero Universitaria di Ferrara, Cona (FE), Italy
| | - Wojciech Wojakowski
- 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
| | - Emad Abu-Assi
- Hospital Universitario Álvaro Cunqueiro, Vigo, Spain
| | - Gianfranco Sinagra
- Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy
| | - Gaetano Maria de Ferrari
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| | - Italo Porto
- DICATOV-Cardiothoracic and Vascular Department, San Martino Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy
| | - Fabrizio D'Ascenzo
- Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences, University of Turin, Turin 10126, Italy
| |
Collapse
|
2
|
Mauro M, Bignardi D, Baiardini I, Bonadonna P, Braschi MC, Emiliani F, Guerra L, Liberati S, Olivieri F, Pravettoni V, Preziosi D, Ridolo E, Rivolta F, Martini M, Bilò MB. Health-related Quality of Life in Hymenoptera Venom Allergy: Validation of the Italian version of the Vespid Allergy Quality of Life Questionnaire (VQLQ-i). Eur Ann Allergy Clin Immunol 2024. [PMID: 38235503 DOI: 10.23822/eurannaci.1764-1489.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2024]
Affiliation(s)
- M Mauro
- Allergy Unit, Division of Pulmonology, S. Anna Hospital, ASST-Lariana, Como, Italy
| | - D Bignardi
- Allergology Unit, IRCCS San Martino Polyclinic Hospital, Genoa, Italy
| | | | - P Bonadonna
- Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy
| | - M C Braschi
- Allergy Unit, Department of Internal Medicine, University Hospital Ospedali Riuniti, Ancona, Italy
| | - F Emiliani
- Allergy Unit, AUSL della Romagna, Faenza, Italy
| | - L Guerra
- Allergology Unit, IRCCS San Martino Polyclinic Hospital, Genoa, Italy
| | - S Liberati
- Allergy Unit, Ospedale Infermi di Rimini, Rimini, Italy
| | - F Olivieri
- Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy
| | - V Pravettoni
- Department of Internal Medicine, IRCCS Foudation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - D Preziosi
- Allergy Unit, Division of Pulmonology, S. Anna Hospital, ASST-Lariana, Como, Italy
| | - E Ridolo
- Allergy and Immunology, University of Parma, Parma, Italy
| | - F Rivolta
- Department of Internal Medicine, IRCCS Foudation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - M Martini
- Allergy Unit, Department of Internal Medicine, University Hospital Ospedali Riuniti, Ancona, Italy
- Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy
| | - M B Bilò
- Allergy Unit, Department of Internal Medicine, University Hospital Ospedali Riuniti, Ancona, Italy
- Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy
| |
Collapse
|
3
|
Arzt-Gradwohl L, Annik Herzog S, Aberer W, Alfaya Arias T, Antolín-Amérigo D, Bonadonna P, Boni E, Bożek A, Chełmińska M, Ernst B, Frelih N, Gawlik R, Gelincik A, Hawranek T, Hoetzenecker W, Jiménez Blanco A, Kita K, Kendirlinan R, Košnik M, Laipold K, Lang R, Marchi F, Mauro M, Nittner-Marszalska M, Poziomkowska-Gęsicka I, Pravettoni V, Preziosi D, Quercia O, Reider N, Rosiek-Biegus M, Ruiz-Leon B, Schrautzer C, Serrano P, Sin A, Ayşe Sin B, Stoevesandt J, Trautmann A, Vachová M, Johannes Sturm G. Influencing factors on the safety and effectiveness of venom immunotherapy. J Investig Allergol Clin Immunol 2023; 35:0. [PMID: 37937715 DOI: 10.18176/jiaci.0967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2023] Open
Abstract
BACKGROUND AND OBJECTIVE The safety profile of venom immunotherapy (VIT) is a relevant issue and considerable differences in safety and efficacy of VIT have been reported. The primary aim of this study was to evaluate the safety of ACE inhibitors and beta-blockers during VIT, which has already been published. For a second analysis, data concerning premedication and venom preparations in relation to systemic adverse events (AE) during the up-dosing phase and the first year of the maintenance phase were evaluated as well as the outcome of field stings and sting challenges. METHODS The study was conducted as an open, prospective, observational, multicenter study. In total, 1,425 patients were enrolled and VIT was performed in 1,342 patients. RESULTS Premedication with oral antihistamines was taken by 52.1% of patients during the up-dosing and 19.7% of patients during the maintenance phase. Taking antihistamines had no effect on the frequency of systemic AE (p=0.11) but large local reactions (LLR) were less frequently seen (OR: 0.74; 95% CI: 0.58-0.96; p=0.02). Aqueous preparations were preferentially used for up-dosing (73.0%) and depot preparations for the maintenance phase (64.5%). The type of venom preparation neither had an influence on the frequency of systemic AE nor on the effectiveness of VIT (p=0.26 and p=0.80, respectively), while LLR were less frequently seen when depot preparations were used (p<0.001). CONCLUSION Pretreatment with oral antihistamines during VIT significantly reduces the frequency of LLR but not systemic AE. All venom preparations used were equally effective and did not differ in the frequency of systemic AE.
Collapse
Affiliation(s)
- L Arzt-Gradwohl
- Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria
| | - S Annik Herzog
- Institute for Medical Informatics, Statistics, and Documentation, Medical University of Graz, Graz, Austria
| | - W Aberer
- Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria
| | - T Alfaya Arias
- Allergy Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - D Antolín-Amérigo
- Servicio de Enfermedades del Sistema Inmune-Alergia, Hospital Universitario Príncipe de Asturias, Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá, Madrid, Spain
- Servicio de Alergia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
| | - P Bonadonna
- Allergy Unit, Verona General Hospital, Verona, Italy
| | - E Boni
- Laboratorio Unico Metropolitano, Maggiore Hospital, Bologna, Italy
| | - A Bożek
- Clinical Department of Internal Diseases, Dermatology, and Allergology, Medical University of Silesia, Zabrze, Poland
| | - M Chełmińska
- Allergology Department, Medical University of Gdańsk, Gdańsk, Poland
| | - B Ernst
- Department of Dermatology, General Hospital Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
| | - N Frelih
- University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
| | - R Gawlik
- Department of Internal Medicine, Allergy, and Clinical Immunology, Silesian University of Medicine, Katowice, Poland
| | - A Gelincik
- Department of Internal Medicine, Division of Immunology and Allergic Diseases, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye
| | - T Hawranek
- Department of Dermatology and Allergology, Paracelsus Medical University Salzburg, Salzburg, Austria
| | - W Hoetzenecker
- Department of Dermatology, Kepler University Hospital and Medical Faculty, Johannes Kepler University, Linz, Austria
| | - A Jiménez Blanco
- Allergy Unit, Hospital Central de la Cruz Roja. Faculty of Medicine, Alfonso X El Sabio University, ARADyAL, Madrid, Spain
| | - K Kita
- Allergology Department, Medical University of Gdańsk, Gdańsk, Poland
| | - R Kendirlinan
- Department of Pulmonary Diseases, Division of Immunology and Allergy, Faculty of Medicine, Ankara University, Ankara, Türkiye
| | - M Košnik
- University Clinic of Respiratory and Allergic Diseases, Golnik and Medical Faculty Ljubljana, Slovenia
| | - K Laipold
- Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria
| | - R Lang
- Department of Dermatology and Allergology, Paracelsus Medical University Salzburg, Salzburg, Austria
| | - F Marchi
- SD Allergologia Clinica, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
| | - M Mauro
- Allergy Unit, Sant´Anna Hospital, Como, Italy
| | - M Nittner-Marszalska
- Department of Internal Diseases, Pulmonology and Allergology, Medical University of Wroclaw, Wroclaw, Poland
| | | | - V Pravettoni
- Department of Internal Medicine, Fondazione IRCCS Ca´ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - D Preziosi
- Allergy Unit, Sant´Anna Hospital, Como, Italy
| | - O Quercia
- High Specialization Unit of Allergology, Hospital of Faenza, AUSL (Local Health Unit) of Romagna, Romagna, Italy
| | - N Reider
- Department of Dermatology, Venereology, and Allergology, Medical University of Innsbruck, Innsbruck, Austria
| | - M Rosiek-Biegus
- Department of Internal Diseases, Pulmonology and Allergology, Medical University of Wroclaw, Wroclaw, Poland
| | - B Ruiz-Leon
- Allergy Section of University Hospital Reina Sofia, ARADyAL Network, Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain
| | - C Schrautzer
- Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria
| | - P Serrano
- Allergy Section of University Hospital Reina Sofia, ARADyAL Network, Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain
| | - A Sin
- Department of Internal Medicine, Division of Allergy and Immunology, Medical Faculty, Ege University, Izmir, Türkiye
| | - B Ayşe Sin
- Department of Pulmonary Diseases, Division of Immunology and Allergy, Faculty of Medicine, Ankara University, Ankara, Türkiye
| | - J Stoevesandt
- Department of Dermatology and Allergy, University Hospital Würzburg, Würzburg, Germany
| | - A Trautmann
- Department of Dermatology and Allergy, University Hospital Würzburg, Würzburg, Germany
| | - M Vachová
- Department of Immunology and Allergology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- Department of Immunology and Allergology, University Hospital Pilsen, Czech Republic
| | - G Johannes Sturm
- Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria
- Allergy Outpatient Clinic Reumannplatz, Vienna, Austria
| |
Collapse
|
4
|
Barocco G, Palei M, Croci E, Savoia A, Mauro M, Stuto F. Guidelines for outsourcing collective catering services in the Friuli Venezia Giulia region. Eur J Public Health 2022. [DOI: 10.1093/eurpub/ckac131.227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Issue
Many stakeholders involved in collective catering services (CCS) of schools, hospitals, elderly care homes, and workplaces of the autonomous region of Friuli Venezia Giulia (ARFVG) have reported some non-compliance with the nutritional, environmental or social standards required by public administrations (PA) procurement contracts (PC), which included the recommendations of the WHO, EU, Ministry of Health, and Ministry of the Environment (MHE).
Description of the problem
The ARFVG prevention plans have set the goal to overcome the critical issues of the regional CCS which serve over 10% of the population (130,000 meals a day). Between 2019 and 2021, a multidisciplinary group of experts from health services and from the association of 215 regional municipalities developed the guidelines (GL) for outsourcing of CCS. The aim was to support PA in the drafting of PC, evaluation of offers and verification of contractual performance. Reference was made to Dir. 2014/24/EU, EU green public procurement criteria for food, catering services and vending machines, the national lines for CCS of MHE. The GL are characterized by the integration between the tender document models and the 8 qualification areas detailed in: restructuring; supplies; environmental impact and sustainability; production processes; personnel qualification and training; nutritional standards; customer satisfaction; and verification and research of quality.
Results
Two regional central purchasing bodies have already used the GL to draft the PC for school CCS of 26 municipalities and for the whole hospital CCS of RAFVG. The application of guidelines in PC has introduced homogeneous high level qualification and verification standards for the CCS of the RAFVG.
Lessons
To ensure the application of food, nutritional, environmental and social policies in CCS, it is essential to activate networks between professionals from different sectors in order to share tools to achieve the common sustainable development goals.
Key messages
• To integrate food, nutritional, environmental and social regional policies into collective catering services, it is essential to apply systemic tools shared by all Public Administrations.
• Central purchasing bodies have the potential to introduce homogeneous and shared high level qualification and verification standards for collective catering services.
Collapse
Affiliation(s)
- G Barocco
- Servizio Igiene Alimenti e Nutrizione, Azienda Sanitaria Universitaria Giuliano Ison , Trieste, Italy
| | - M Palei
- Servizio Prevenzione, Sicurezza Alimentare, Direzione Centrale Salute, Regione FVG , Trieste, Italy
| | - E Croci
- Servizio Igiene Alimenti e Nutrizione, Azienda Sanitaria Universitaria Giuliano Ison , Trieste, Italy
| | - A Savoia
- Servizio Igiene Alimenti e Nutrizione, Azienda Sanitaria Universitaria Friuli Centra , Udine, Italy
| | - M Mauro
- Servizio Igiene Alimenti e Nutrizione, Azienda Sanitaria Universitaria Friuli Centra , Udine, Italy
| | - F Stuto
- Servizio Igiene Alimenti e Nutrizione, Azienda Sanitaria Friuli Occidentale , Pordenone, Italy
| |
Collapse
|
5
|
Mauro M, Cammilleri G, Celi M, Cicero A, Arizza V, Ferrantelli V, Vazzana M. Effects of diclofenac on the gametes and embryonic development of Arbacia lixula. The European Zoological Journal 2022. [DOI: 10.1080/24750263.2022.2059582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Affiliation(s)
- M. Mauro
- Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Dipartimento di Scienze e, Palermo, Italia
| | - G. Cammilleri
- Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italia
| | - M. Celi
- Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Dipartimento di Scienze e, Palermo, Italia
| | - A. Cicero
- Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italia
| | - V. Arizza
- Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Dipartimento di Scienze e, Palermo, Italia
| | - V. Ferrantelli
- Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italia
| | - M. Vazzana
- Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Dipartimento di Scienze e, Palermo, Italia
| |
Collapse
|
6
|
Piapan L, De Michieli P, Ronchese F, Rui F, Mauro M, Peresson M, Segat L, D'Agaro P, Negro C, Bovenzi M, Larese Filon F. COVID-19 outbreak in healthcare workers in hospitals in Trieste, North-east Italy. J Hosp Infect 2020; 106:626-628. [PMID: 32805309 PMCID: PMC7427613 DOI: 10.1016/j.jhin.2020.08.012] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2020] [Accepted: 08/11/2020] [Indexed: 11/30/2022]
Affiliation(s)
- L Piapan
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - P De Michieli
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - F Ronchese
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - F Rui
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - M Mauro
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - M Peresson
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - L Segat
- Unit of Public Health, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - P D'Agaro
- Unit of Public Health, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - C Negro
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - M Bovenzi
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy
| | - F Larese Filon
- Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Trieste, Italy.
| |
Collapse
|
7
|
Asero R, Abbadessa S, Aruanno A, Barilaro G, Barzaghi C, Bignardi D, Bilò MB, Borro M, Bresciani M, Busa M, Buzzulini F, Cavaliere C, Cecchi L, Ciccarelli A, Cortellini G, Cucinelli F, Deleonardi G, Emiliani F, Farsi A, Ferrarini E, Franchini M, Ingrassia A, Lippolis D, Losappio L, Marra AM, Martini M, Masieri S, Mauro M, Mazzolini M, Muratore L, Murzilli F, Nucera E, Pastorello EA, Pinter E, Polillo BR, Pravettoni V, Quercia O, Rizzi A, Russello M, Sacerdoti C, Scala E, Scala G, Scarpa A, Schroeder J, Uasuf CG, Villalta D, Yang B, Mistrello G, Amato S, Lidholm J. Detection of Gibberellin-Regulated Protein (Peamaclein) Sensitization among Italian Cypress Pollen-Sensitized Patients. J Investig Allergol Clin Immunol 2020; 32:40-47. [DOI: 10.18176/jiaci.0542] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
8
|
Larese Filon F, Miani A, Corradin M, Belloni Fortina A, Mauro M. Quaternium‐15 sensitization in the north‐east of Italy, trend from 1996 to 2016 and occupational role. J Eur Acad Dermatol Venereol 2020; 34:e317-e319. [DOI: 10.1111/jdv.16222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- F. Larese Filon
- Unit of Occupational Medicine University of Trieste Trieste Italy
| | - A. Miani
- Unit of Occupational Medicine University of Trieste Trieste Italy
| | - M.T. Corradin
- Dermatologic Unit Ospedale di Santa Maria degli Angeli Pordenone Italy
| | | | - M. Mauro
- Unit of Occupational Medicine University of Trieste Trieste Italy
| |
Collapse
|
9
|
Asero R, Aruanno A, Bresciani M, Brusca I, Carollo M, Cecchi L, Cortellini G, Deleonardi G, Farsi A, Ferrarini E, Gabrielli G, Ingrassia A, Mauro M, Murzilli F, Nucera E, Onida R, Pastorello EA, Pinter E, Rizzi A, Russello M, Sacerdoti C, Scala E, Scala G, Villalta D, Zampogna S, Amato S, Mistrello G. Evaluation of two commercial peach extracts for skin prick testing in the diagnosis of hypersensitivity to lipid transfer protein. A multicenter study. Eur Ann Allergy Clin Immunol 2020; 53:168-170. [PMID: 32347686 DOI: 10.23822/eurannaci.1764-1489.144] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Summary The clinical usefulness of two commercial peach extracts for SPT (by Lofarma SpA and ALK-Abellò, respectively) was compared in a multicenter study carried out in Italy. Peach allergic patients were tested with the two extracts in parallel and underwent the detection of IgE specific for all three peach allergens currently available (Pru p1, Pru p3, and Pru p4, respectively). The two extracts were almost identical in terms of sensitivity and specificity, being able to detect virtually all patients sensitized to stable peach allergens (lipid transfer protein (LTP) and, presumably, peamaclein) but scoring negative in patients exclusively sensitive to labile allergens (either PR-10 and/or profilin). Thus, the two extracts represent an excellent tool to carry out a preliminary component-resolved diagnosis of peach allergy at the first patient visit.
Collapse
Affiliation(s)
- R Asero
- Allergology Clinic, Clinica San Carlo, Paderno Dugnano, Milan, Italy
| | - A Aruanno
- Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy
| | - M Bresciani
- Allergology Clinic, Asl RM 4, S. Paolo Civitavecchia Hospital, Civitavecchia, Italy
| | - I Brusca
- Clinical Pathology U.O.C., Buccheri La Ferla F.B.F. Hospital, Palermo, Italy
| | - M Carollo
- Pathology and Clinical Biochemistry, Magna Graecia University, Catanzaro, Italy
| | - L Cecchi
- Allergology and Immunology SOS, Prato-Azienda USL Toscana Centro, Prato, Italy
| | - G Cortellini
- Romagna Allergy Unit, Internist Department of Rimini, Rimini, Italy
| | - G Deleonardi
- Laboratorio Unico Metropolitano, AUSL Bologna, Bologna, Italy
| | - A Farsi
- Allergology and Immunology SOS, Prato-Azienda USL Toscana Centro, Prato, Italy
| | - E Ferrarini
- Allergology OUS, Umberto I Hospital, Siracusa, Italy
| | - G Gabrielli
- School of Specialization in Allergy and Clinical Immunology, Alma Mater Studiorum, Bologna, Italy
| | - A Ingrassia
- Allergology UO, District of Marsala, ASP 9, Trapani, Italy
| | - M Mauro
- Allergology UO, ASST Lariana, Como, Italy
| | - F Murzilli
- Allergology U.O.S.D., S.S. Filippo e Nicola Hospital, Avezzano, Italy
| | - E Nucera
- Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy
| | - R Onida
- Clinical Pathology U.O.C., Buccheri La Ferla F.B.F. Hospital, Palermo, Italy
| | - E A Pastorello
- Struttura Complessa di Allergologia e Immunologia, ASST GOM, Niguarda, Milan, Italy
| | - E Pinter
- Clinic Immunology U.O.C., Policlinico Umberto Primo, Rome, Italy
| | - A Rizzi
- Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy
| | - M Russello
- Allergology UO, ASST Lariana, Como, Italy
| | | | - E Scala
- Istituto Dermopatico dell'Immacolata, Rome, Italy
| | - G Scala
- Allergology UOSD, Loreto Crispi, ASL Napoli 1 Centro, Naples, Italy
| | - D Villalta
- Immunology and Allergology Unit, Santa Maria degli Angeli Hospital, Pordenone, Italy
| | - S Zampogna
- Pediatric First Aid, Pugliese Ciaccio Hospital, Catanzaro, Italy
| | - S Amato
- Lofarma SpA, R and D, Milan, Italy
| | | |
Collapse
|
10
|
Mauro M, Crosera M, Bovenzi M, Basso P, Adami G, Maina G, Baracchini E, Larese Filon F. Corrigendum to “In vitro transdermal absorption of Al2O3 nanoparticles” Toxicol In Vitro, 2019 Apr 17;59:275-280. Toxicol In Vitro 2019; 59:322. [DOI: 10.1016/j.tiv.2019.05.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
11
|
Mauro M, De Grandis RA, Campos ML, Bauermeister A, Peccinini RG, Pavan FR, Lopes NP, De Moraes NV. Acid diterpenes from Copaiba oleoresin (Copaifera langsdorffii): Chemical and plasma stability and intestinal permeability using Caco-2 cells. J Ethnopharmacol 2019; 235:183-189. [PMID: 30763698 DOI: 10.1016/j.jep.2019.02.017] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2018] [Revised: 02/04/2019] [Accepted: 02/10/2019] [Indexed: 06/09/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Copaiba oleoresin has been used in folk medicine in the treatment of bronchitis, syphilis, skin diseases and ulcers due to its anti-inflammatory and antiseptic activities, but there is no information about major compounds oral absorption to support the traditional use. AIM OF STUDY Considering the potential of copalic (CA) and kaurenoic acid (KA) - major biological activity (in vitro) diterpenes found in the oleoresin, this study aimed to evaluate the intestinal permeability of CA and KA using Caco-2 cells model as predictive test for oral drug absorption. MATERIALS AND METHODS Chemical stability at pH 1.2 and 7.4 and plasma stability were evaluated to mimic physiological conditions of the gastrointestinal tract. The intestinal permeability of CA and KA was evaluated in Caco-2 cells in the presence and absence of the P-glycoprotein inhibitor verapamil. RESULTS CA and KA were rapidly degraded at pH 1.2 (0.2 M Clark-Lubs buffer). At pH 7.4 (0.1 M phosphate buffer), CA was stable for up to 24 h and KA for up to 6 h. In human plasma, CA and KA can be considered stable for 24 h and 12 h at 37 °C, respectively. Caco-2 cells were considered viable when incubated with CA or KA in the range of 3.9-250 μM for 24 h. CA and KA exhibited moderate apparent permeability (Papp) of 4.67 (±0.08) × 10-6 cm/s and 4.66 (±0.04) × 10-6 cm/s, respectively. Simultaneous incubation with verapamil showed that P-glycoprotein does not play a relevant role on CA and KA oral absorption, with Papp of 4.48 (±0.26) × 10-6 cm/s and 5.37 (±0.72) × 10-6 cm/s observed for CA and KA, respectively. CONCLUSION The oral absorption of both CA and KA is driven by mainly passive permeability, is not limited by p-glycoprotein, but enteric-coated dosage forms should be used to avoid chemical instability in the gastric pH.
Collapse
Affiliation(s)
- M Mauro
- São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP ZIP 14801-902, Brazil.
| | - R A De Grandis
- São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP ZIP 14801-902, Brazil.
| | - M L Campos
- Federal University of Mato Grosso, Sinop, MT, Brazil.
| | - A Bauermeister
- University of Sao Paulo (USP), NPPNS, School of Pharmaceutical Sciences of Ribeirao Preto, Ribeirao Preto, SP ZIP 14040-903, Brazil.
| | - R G Peccinini
- São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP ZIP 14801-902, Brazil.
| | - F R Pavan
- São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP ZIP 14801-902, Brazil.
| | - N P Lopes
- University of Sao Paulo (USP), NPPNS, School of Pharmaceutical Sciences of Ribeirao Preto, Ribeirao Preto, SP ZIP 14040-903, Brazil.
| | - N V De Moraes
- São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP ZIP 14801-902, Brazil.
| |
Collapse
|
12
|
Dusefante A, Mauro M, Belloni Fortina A, Corradin M, Larese Filon F. Contact allergy to methylchloroisothiazolinone/methylisothiazolinone in north‐eastern Italy: a temporal trend from 1996 to 2016. J Eur Acad Dermatol Venereol 2019; 33:912-917. [DOI: 10.1111/jdv.15453] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Accepted: 12/19/2018] [Indexed: 11/28/2022]
Affiliation(s)
- A. Dusefante
- Clinical Unit of Occupational Medicine University of Trieste Trieste Italy
| | - M. Mauro
- Clinical Unit of Occupational Medicine University of Trieste Trieste Italy
| | | | | | - F. Larese Filon
- Clinical Unit of Occupational Medicine University of Trieste Trieste Italy
| |
Collapse
|
13
|
Bilò MB, Pravettoni V, Bignardi D, Bonadonna P, Mauro M, Novembre E, Quercia O, Cilia M, Cortellini G, Costantino MT, Cremonte L, Lodi Rizzini F, Macchia L, Marengo F, Murzilli F, Patella V, Reccardini F, Ricciardi L, Ridolo E, Romano A, Savi E, Schiavino D, Severino M, Pastorello EA. Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice. J Investig Allergol Clin Immunol 2018; 29:180-205. [PMID: 30183660 DOI: 10.18176/jiaci.0310] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Hymenoptera venom allergy is an epidemiologically underestimated condition and a major cause of morbidity worldwide. Preventing future allergic reactions in patients who experience a systemic reaction is based on the correct management of the emergency followed by an accurate diagnosis, prescription of adrenaline autoinjectors, and, where indicated, specific venom immunotherapy. Some epidemiological studies highlight our poor knowledge of this disease and the frequent inadequacy of its management. Moreover, they emphasize the importance of such a life-saving treatment as specific immunotherapy. The availability of high-quality hymenoptera venom extracts for diagnostic and therapeutic use has dramatically improved the prognosis and quality of life of allergic patients. Subcutaneous venom immunotherapy is currently the most effective form of allergen-based immunotherapy, with a carry-over effect lasting up to several years after its interruption. This report on the management of hymenoptera venom-allergic children and adults was prepared by a panel of Italian experts. The main objective of this consensus document is to review the scientific evidence related to diagnosis, therapy, and management of patients allergic to hymenoptera venom. Thus, we can improve our knowledge of the disease and promote good clinical practices. The present document provides practical suggestions for correct diagnosis, prescription of emergency therapy and immunotherapy, and strategies for patient care.
Collapse
Affiliation(s)
- M B Bilò
- U.O.C. Allergology, Department of Internal Medicine, University-Hospital Ospedali Riuniti di Ancona, Italy
| | - V Pravettoni
- U.O.C. General Medicine - Immunology and Allergology, Foundation IRCCS Ca´ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - D Bignardi
- U.O.C. Allergology, Ospedale Policlinico San Martino, Genova, Italy
| | - P Bonadonna
- U.S.D. Allergology, Integrated University-Hospital of Verona, Italy
| | - M Mauro
- U.O.S. Allergology, Hospital S. Anna Como ASST Lariana, Italy
| | - E Novembre
- Complex Organizational Unit of Allergology, University-Hospital A. Meyer, Firenze, Italy
| | - O Quercia
- High Specialization Unit of Allergology, Hospital of Faenza, AUSL (Local Health Unit) of Romagna, Italy
| | - M Cilia
- Allergology Practice, C.d.S. of Scilla, Reggio Calabria, Italy
| | - G Cortellini
- Allergology, O.U. Internal Medicine and Rheumatology, Rimini, Local Health Unit of Romagna, Italy
| | - M T Costantino
- Departmental Structure Day Hospital Center, Allergology and Clinic Immunology Local Health Unit of Mantova, Intercompany Allergology ATS Val Padana, Italy
| | - L Cremonte
- SS Allergologia ASL AL Alessandria, Italy
| | - F Lodi Rizzini
- S.S.V.D. Allergology Civil Hospitals of Brescia, Department of Clinical and Experimental Sciences University of Brescia, Italy
| | - L Macchia
- School and Chair of Allergology and Clinical Immunology, University of Bari, Italy
| | - F Marengo
- Allergology and Clinical Immunology, A.O.U. Città della Salute e della Scienza di Torino
| | - F Murzilli
- U.O.S.D. of Allergology Hospital S.S. Filippo and Nicola, Avezzano (AQ), Italy
| | - V Patella
- Allergy and Clinical Immunology Division, Department of Medicine, Civil Hospital of Battipaglia, Salerno, Italy
| | - F Reccardini
- SOC Pneumology, Respiratory Physiopathology, integrated University Health Authority of Udine, Italy
| | - L Ricciardi
- Allergy and Clinical Immunology Unit - University Hospital AOU Policlinico G.Martino, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - E Ridolo
- Department of Medicine and Surgery, University of Parma, Italy
| | - A Romano
- Unit of Allergology, Presidio Columbus, Rome, Italy
| | - E Savi
- Operating Departmental Unit of Allergology, Hospital G. Da Saliceto, Piacenza, Italy
| | - D Schiavino
- Complex Operating Unit of Allergology, Policlinico Gemelli - School of Specialization in Allergology and Clinical Immunology, Catholic University, Rome, Italy
| | - M Severino
- Allergy Unit, San Giovanni di Dio Hospital, Florence, Italy
| | - E A Pastorello
- Complex Unit of Allergology and Immunology at ASST Grande Ospedale Metropolitano Niguarda - School of Specialization in Allergology and Clinical Immunology at University of Milan, Italy
| |
Collapse
|
14
|
Frati F, Scurati S, Puccinelli P, Morviducci C, Di Cara G, Boccardo R, Piergentili E, Milioni M, Bernardini R, Sambugaro R, Castellano F, Varricchio A, Manfredi G, Cordero L, Russello M, Guercio E, Mauro M, Incorvaia C. Inflammation in Respiratory Allergy Treated by Sublingual Immunotherapy. EUR J INFLAMM 2017. [DOI: 10.1177/1721727x0900700301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The most common allergic diseases, such as rhinitis, asthma and atopic dermatitis, are sustained by allergic inflammation, the treatment of which requires anti-inflammatory activity. Among the available treatments, allergen immunotherapy (IT) has a documented impact on allergic inflammation which persists after its discontinuation and modifies the natural course of allergy. The anti-inflammatory effects of IT, and particularly of sublingual IT (SLIT), are based on the ability to modify the phenotype of T cells which, in allergic subjects, are characterized by a prevalence of the Th2 type, with production of IL-4, IL-5, IL-13, IL-17, and IL-32 cytokines. IT-induced changes result in a Th1-type response (immune deviation) related to an increased IFN-gamma and IL-2 production or in a Th2 reduced activity, through a mechanism of anergy or tolerance. It is now known that T cell tolerance is characterized by the generation of allergen-specific Treg cells, which produce cytokines such as IL-10 and TGF-beta with immunosuppressant and/or immunoregulatory activity. Recent studies suggest that the anti-inflammatory mechanism of SLIT is similar to classical, subcutaneous IT, with a prominent role in SLIT for mucosal dendritic cells. The tolerance pattern induced by Treg accounts for the suppressed or reduced activity of inflammatory cells and for the isotypic switch of antibody synthesis from IgE to IgG, and especially to IgG4. Data obtained from biopsies clearly indicate that the pathophysiology of the oral mucosa plays a pivotal role in inducing tolerance to the sublingually administered allergen.
Collapse
Affiliation(s)
- F. Frati
- Pediatrics, University Department of Medical and Surgical Specialty and Public Health, Perugia
- Medical and Scientific Department, Stallergenes, Milan
| | - S. Scurati
- Medical and Scientific Department, Stallergenes, Milan
| | - P. Puccinelli
- Medical and Scientific Department, Stallergenes, Milan
| | | | - G. Di Cara
- Pediatrics, University Department of Medical and Surgical Specialty and Public Health, Perugia
| | - R. Boccardo
- Pediatrics, University Department of Medical and Surgical Specialty and Public Health, Perugia
| | - E. Piergentili
- Pediatrics, University Department of Medical and Surgical Specialty and Public Health, Perugia
| | - M. Milioni
- Pediatrics, University Department of Medical and Surgical Specialty and Public Health, Perugia
| | | | | | | | | | - G. Manfredi
- Clinical Immunology, Miulli Hospital, Acquaviva delle Fonti
| | - L. Cordero
- Pneumology Unit, University Hospital, Sassari
| | | | - E. Guercio
- General Hospital, Castrovillari, Cosenza
| | - M. Mauro
- Allergy Unit, Sant'Anna Hospital, Como
| | - C. Incorvaia
- Allergy/Pulmonary rehabilitation Unit, ICP Hospital, Milan, Italy
| |
Collapse
|
15
|
Coppel R, Gomez AL, Finet G, Mauro M, Pettigrew RI, Ohayon J, Lagache M. Experimental Bench for Hemodynamic Study of Coronary Artery with Serial Stenoses: Fractional Flow Reserve Assessment. Comput Methods Biomech Biomed Engin 2017; 20:45-46. [PMID: 29088640 DOI: 10.1080/10255842.2017.1382853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- R Coppel
- a Laboratory TIMC-IMAG/DyCTiM2 , UJF, CNRS UMR 5525 , Grenoble , France
| | - A L Gomez
- a Laboratory TIMC-IMAG/DyCTiM2 , UJF, CNRS UMR 5525 , Grenoble , France
| | - G Finet
- b Department of Hemodynamics and Interventional Cardiology , Hospices Civils de Lyon and Claude Bernard University Lyon1, INSERM Unit 886 , Lyon , France
| | - M Mauro
- c Department of Mechanical Engineering, Energetics and Materials , Public University of Navarra , Pamplona , Spain
| | - R I Pettigrew
- d Laboratory of Integrative Cardiovascular Imaging Science , National Institute of Diabetes Digestive and Kidney Diseases, National Institutes of Health , Bethesda , MD , USA
| | - J Ohayon
- a Laboratory TIMC-IMAG/DyCTiM2 , UJF, CNRS UMR 5525 , Grenoble , France.,e University of Savoie Mont-Blanc, Polytech Annecy-Chambéry , Le Bourget du Lac , France
| | - M Lagache
- e University of Savoie Mont-Blanc, Polytech Annecy-Chambéry , Le Bourget du Lac , France.,f Laboratory SYMME , Chambéry , France
| |
Collapse
|
16
|
Larese Filon F, Plazzotta S, Rui F, Mauro M, De Michieli P, Negro C. Ten-year incidence of contact dermatitis in a prospective cohort of healthcare workers in Trieste hospitals (North East of Italy) 2004-2013. Br J Dermatol 2017; 177:560-561. [PMID: 27718523 DOI: 10.1111/bjd.15118] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- F Larese Filon
- Unità Clinico Operativa di Medicina del Lavoro, Dipartimento di Scienze di Medicina Pubblica, Università degli Studi di Trieste, Via della Pietà, 19-24120, Trieste, Italy
| | - S Plazzotta
- Unità Clinico Operativa di Medicina del Lavoro, Dipartimento di Scienze di Medicina Pubblica, Università degli Studi di Trieste, Via della Pietà, 19-24120, Trieste, Italy
| | - F Rui
- Unità Clinico Operativa di Medicina del Lavoro, Dipartimento di Scienze di Medicina Pubblica, Università degli Studi di Trieste, Via della Pietà, 19-24120, Trieste, Italy
| | - M Mauro
- Unità Clinico Operativa di Medicina del Lavoro, Dipartimento di Scienze di Medicina Pubblica, Università degli Studi di Trieste, Via della Pietà, 19-24120, Trieste, Italy
| | - P De Michieli
- Unità Clinico Operativa di Medicina del Lavoro, Dipartimento di Scienze di Medicina Pubblica, Università degli Studi di Trieste, Via della Pietà, 19-24120, Trieste, Italy
| | - C Negro
- Unità Clinico Operativa di Medicina del Lavoro, Dipartimento di Scienze di Medicina Pubblica, Università degli Studi di Trieste, Via della Pietà, 19-24120, Trieste, Italy
| |
Collapse
|
17
|
Parisi MG, Mauro M, Sarà G, Cammarata M. Temperature increases, hypoxia, and changes in food availability affect immunological biomarkers in the marine mussel Mytilus galloprovincialis. J Comp Physiol B 2017; 187:1117-1126. [PMID: 28389696 DOI: 10.1007/s00360-017-1089-2] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Revised: 03/01/2017] [Accepted: 03/15/2017] [Indexed: 01/06/2023]
Abstract
Temperature increases, hypoxia, and changes in food availability are predicted to occur in the future. There is growing concern for the health status of wild and farmed organisms, since environmental stressors alter organism functions, and elicit coordinated physiological responses for homeostasis. Mussels are good bioindicators of environmental conditions. Their ability to maintain unaltered immunosurveillance under adverse environmental conditions may enhance their survival capability. Few studies are currently concerned with the relationships and feedback among multiple stressors. Here, food concentration, temperature, and oxygenation treatments were evaluated for their effects on immune enzymatic parameters of Mytilus galloprovincialis detected in the digestive gland and the lysosomal viability by neutral red uptake. Mussels were exposed to three temperatures (12, 20, and 28 °C) under normoxic (8 mg O2l-1) and anoxic conditions and specimens were fed with six food concentrations, ranging 0.2-5 g chlorophyll l-1. Temperature increases affected esterase and alkaline phophatase enzyme functionality, and addition of food buffered detrimental effects generated by harsh conditions, such as those provided by low oxygen concentrations. Kinetics of the phenoloxidase was negatively correlated with increasing temperature. In this case, food had a buffering effect that counteracted the limiting temperature only under normoxic conditions. In addition, the stability of the lysosomal membrane was altered under conditions of thermal stress and food change, under normoxic and anoxic conditions. Overall, environmental stress factors affected immune biomarkers of Mediterranean mussels, and the level of food acted as a buffer, increasing the thermal resistance of the specimens.
Collapse
Affiliation(s)
- M G Parisi
- Marine Immunobiology laboratory, University of Palermo, CONISMA, Via Archirafi 18, 90128, Palermo, Italy.
| | - M Mauro
- Marine Immunobiology laboratory, University of Palermo, CONISMA, Via Archirafi 18, 90128, Palermo, Italy
| | - G Sarà
- Dipartimento di Scienze della Terra e del Mare, University of Palermo, Viale delle Scienze Ed. 16, 90128, Palermo, Italy
| | - M Cammarata
- Marine Immunobiology laboratory, University of Palermo, CONISMA, Via Archirafi 18, 90128, Palermo, Italy
| |
Collapse
|
18
|
Mauro M, De Giusti V, Bovenzi M, Larese Filon F. Effectiveness of a secondary prevention protocol for occupational contact dermatitis. J Eur Acad Dermatol Venereol 2016; 31:656-663. [DOI: 10.1111/jdv.13947] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Accepted: 07/18/2016] [Indexed: 01/20/2023]
Affiliation(s)
- M. Mauro
- Clinical Unit of Occupational Medicine; Department of Medical Sciences; University of Trieste; Trieste Italy
| | - V. De Giusti
- Clinical Unit of Occupational Medicine; Department of Medical Sciences; University of Trieste; Trieste Italy
| | - M. Bovenzi
- Clinical Unit of Occupational Medicine; Department of Medical Sciences; University of Trieste; Trieste Italy
| | - F. Larese Filon
- Clinical Unit of Occupational Medicine; Department of Medical Sciences; University of Trieste; Trieste Italy
| |
Collapse
|
19
|
Guadagno L, Raimondo M, Vertuccio L, Mauro M, Guerra G, Lafdi K, De Vivo B, Lamberti P, Spinelli G, Tucci V. Optimization of graphene-based materials outperforming host epoxy matrices. RSC Adv 2015. [DOI: 10.1039/c5ra04558d] [Citation(s) in RCA: 64] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Graphitic layers are designed as a self-assembly structure using edge-carboxylated layers approach. The functionalization facilitate the interfacial interaction between polymer and carbon layers enhancing electrical and mechanical performance.
Collapse
Affiliation(s)
- L. Guadagno
- Department of Industrial Engineering
- University of Salerno
- Fisciano (SA) 84084
- Italy
| | - M. Raimondo
- Department of Industrial Engineering
- University of Salerno
- Fisciano (SA) 84084
- Italy
| | - L. Vertuccio
- Department of Industrial Engineering
- University of Salerno
- Fisciano (SA) 84084
- Italy
| | - M. Mauro
- Department of Chemistry and Biology
- University of Salerno
- Fisciano (SA)
- Italy
| | - G. Guerra
- Department of Chemistry and Biology
- University of Salerno
- Fisciano (SA)
- Italy
| | - K. Lafdi
- University of Dayton
- Dayton Ohio
- USA
| | - B. De Vivo
- Department of Information Engineering
- Electrical Engineering and Mathematics Applied University of Salerno
- Fisciano (SA)
- Italy
| | - P. Lamberti
- Department of Information Engineering
- Electrical Engineering and Mathematics Applied University of Salerno
- Fisciano (SA)
- Italy
| | - G. Spinelli
- Department of Information Engineering
- Electrical Engineering and Mathematics Applied University of Salerno
- Fisciano (SA)
- Italy
| | - V. Tucci
- Department of Information Engineering
- Electrical Engineering and Mathematics Applied University of Salerno
- Fisciano (SA)
- Italy
| |
Collapse
|
20
|
Prock J, Strabler C, Viertl W, Kopacka H, Obendorf D, Müller T, Tordin E, Salzl S, Knör G, Mauro M, De Cola L, Brüggeller P. Unusual stability of dyads during photochemical hydrogen production. Dalton Trans 2015; 44:20936-48. [DOI: 10.1039/c5dt03414k] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Heterodimetallic dyads containing Os and Pd are connected by a bis(bidentate) phosphine and show an excellent stability for the water splitting application.
Collapse
|
21
|
Mauro M, Incorvaia C, Formigoni C, Elia R, Russello M, Pellegrino D. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology. Panminerva Med 2012; 54:305-312. [PMID: 23123583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The immunoglobulin E (IgE) are a key factor in the pathophysiology of allergic diseases and the important therapeutic role of an anti-IgE antibody was long envisioned. It took time and efforts to solve the safety problems related to the anaphylactogen capacity of anti-IgE, finally crowned by the introduction of the humanized, monoclonal anti-IgE antibody omalizumab. Currently, omalizumab is indicated, based on clear evidence of efficacy, only in severe allergic asthma not controlled by conventional treatment. However, a continuously increasing amount of literature shows that omalizumab is efficacious in a number of disorders concerning the upper and lower airway and the skin, and, most importantly, in anaphylaxis. The latter application was demonstrated successful in placebo-controlled trials and warrants for a new, life-saving, indication for omalizumab. Also, the systemic reactions precluding the performance of allergen immunotherapy, especially concerning Hymenoptera venom, were prevented by omalizumab treatment. The most surprising success of omalizumab regards clinical conditions thus far considered unrelated to IgE antibodies. This is true for intrinsic asthma and for idiopathic urticaria (demonstrated by a placebo-controlled trial), and angioedema, suggesting in these condition a pathophysiologic role of IgE. These observations support a off-label use of omalizumab in patients suffering from IgE-related pathologies other than asthma who are at risk of fatal events or are uncontrolled by the optimal standard treatment.
Collapse
Affiliation(s)
- M Mauro
- Allergy Unit, Sant'Anna Hospital, Como, Italy
| | | | | | | | | | | |
Collapse
|
22
|
Incorvaia C, Mauro M, Monsalve RI, Vega A, Marqués L, Miranda A, Fernández J, Soriano V, Cruz S, Domínguez-Noche C, Sánchez-Morillas L, Armisen-Gil M, Guspí R, Barber D. Can component-resolved diagnosis overturn the current knowledge on vespid allergy? Allergy 2012; 67:966; author reply 966-7. [PMID: 22676064 DOI: 10.1111/j.1398-9995.2012.02839.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- C. Incorvaia
- Allergy/Pulmonary Rehabilitation Unit; ICP Hospital; Milan; Italy
| | - M. Mauro
- Allergy Unit; Sant'Anna Hospital; Como; Italy
| | | | - A. Vega
- Hospital Universitario de Guadalajara; Guadalajara; Spain
| | - L. Marqués
- Hospital Santa Maria - Universitari Arnau de Vilanova; Lleida; Spain
| | | | - J. Fernández
- Hospital General Universitario de Alicante; Alicante; Spain
| | - V. Soriano
- Hospital General Universitario de Alicante; Alicante; Spain
| | - S. Cruz
- Hospital Torrecardenas; Almería; Spain
| | | | | | - M. Armisen-Gil
- Hospital Provincial de Santiago de Compostela; Santiago de Compostela; Spain
| | - R. Guspí
- Hospital de Tortosa; Verge de la Cinta; Institut de Investigació Sanitaria Pere i Virgili (IISPV); Tortosa; Spain
| | | |
Collapse
|
23
|
Sciandrello G, Mauro M, Catanzaro I, Saverini M, Caradonna F, Barbata G. Long-lasting genomic instability following arsenite exposure in mammalian cells: the role of reactive oxygen species. Environ Mol Mutagen 2011; 52:562-568. [PMID: 21520292 DOI: 10.1002/em.20657] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2009] [Revised: 03/09/2011] [Accepted: 03/09/2011] [Indexed: 05/30/2023]
Abstract
Previously, we reported that the progeny of mammalian cells, which has been exposed to sodium arsenite for two cell cycles, exhibited chromosomal instability and concurrent DNA hypomethylation, when they were subsequently investigated after two months of subculturing (about 120 cell generations) in arsenite-free medium. In this work, we continued our investigations of the long-lasting arsenite-induced genomic instability by analyzing additional endpoints at several time points during the cell expanded growth. In addition to the progressive increase of aneuploid cells, we also noted micronucleated and multinucleated cells that continued to accumulate up to the 50th cell generation, as well as dicentric chromosomes and/or telomeric associations and other complex chromosome rearrangements that began to appear much later, at the 90th cell generation following arsenite exposure. The increasing genomic instability was further characterized by an increased frequency of spontaneous mutations. Furthermore, the long-lasting genomic instability was related to elevated levels of reactive oxygen species (ROS), which at the 50th cell generation appeared higher than in stable parental cells. To gain additional insight into the continuing genomic instability, we examined several individual clones isolated at different time points from the growing cell population. Chromosomally and morphologically unstable cell clones, the number of which increased with the expanded growth, were also present at early phases of growth without arsenite. All genomically unstable clones exhibited higher ROS levels than untreated cells suggesting that oxidative stress is an important factor for the progression of genomic instability induced by arsenite.
Collapse
Affiliation(s)
- G Sciandrello
- Department of Cellular and Developmental Biology, University of Palermo - Viale delle Scienze, Edificio, Palermo, Italy.
| | | | | | | | | | | |
Collapse
|
24
|
Frega A, Lukic A, Fabiano V, Mauro M, Giovagnoli M, Moscarini M, French D. P1008 HPV E6/E7 mRNA expression as possible biomarker in preneoplastic cervical lesions at risk of progression. Int J Gynaecol Obstet 2009. [DOI: 10.1016/s0020-7292(09)62494-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Severino M, Bonadonna P, Bilò MB, Cortellini G, Mauro M, Schiappoli M, Macchia D, Campi P, Manfredi M, Passalacqua G. Safety and efficacy of immunotherapy with Polistes dominulus venom: results from a large Italian database. Allergy 2009; 64:1229-30. [PMID: 19416139 DOI: 10.1111/j.1398-9995.2009.02030.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- M Severino
- Allergy and Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, Genoa 16132, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Incorvaia C, Pravettoni C, Mauro M, Yacoub MR, Tarantini F, Riario-Sforza GG. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis. Monaldi Arch Chest Dis 2008; 69:78-80. [PMID: 18837422 DOI: 10.4081/monaldi.2008.401] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
The anti-IgE antibody omalizumab is currently indicated in severe asthma not controlled by standard drug therapy. Recently, new indications for omalizumab were suggested, which include atopic dermatitis (AD), a skin disorder characterized by elevated levels of IgE. We report the case of a 39-year old woman with severe asthma and severe AD, both resistant to conventional drug treatment. The patient had a IgE level of 1304 kU/L, which exceeded the recommended maximum level for treating asthma with omalizumab (stated in 700 Ku/L) but was far lower than previously reported in cases of AD treated with anti-IgE. The treatment consisted of a dose of omalizumab 375 mg every two weeks, and induced a rapid improvement of asthma, with no need of other drugs after three months, along with a progressive decline of severity of AD, which after five months was completely cured. These findings suggest the usefulness of omalizumab in patients with concomitant severe asthma and AD, also considering the pharmaco-economic balance obtained by withdrawing the multiple drugs used to treat both diseases.
Collapse
Affiliation(s)
- C Incorvaia
- Pulmonary Rehabilitation Dept., ICP Hospital, Milan, Italy.
| | | | | | | | | | | |
Collapse
|
27
|
Bovenzi M, Mauro M, Ronchese F, Larese Filon F. [Neck and upper limb disorders caused by combined exposures to ergonomic risk factors and hand-transmitted vibration]. G Ital Med Lav Ergon 2008; 30:39-45. [PMID: 19288788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
A review of neck and upper limb disorders caused by combined exposures to hand-transmitted vibration and ergonomic risk factors (repetitiveness, force, posture) suggested the following conclusions: (1) hand-transmitted vibration has a dominant role in the etiopathogenesis of Raynaud's phenomenon and various forms of peripheral neuropathy with sensory impairment (digital, multifocal) in users of vibrating tools; (2) vibration of low frequency and high amplitude from percussive tools concur, together with adverse ergonomic factors, to produce degenerative changes in the bones and joints of the upper limbs, mainly in the wrist and elbow; (3) there is strong epidemiological and experimental evidence that combined exposures to hand-transmitted vibration and physical load are associated with an excess risk of carpal tunned syndrome; (4) there is limited evidence for an association between Dupuytren's contracture and vibration exposure owing to the small number of currently available epidemiological studies; (5) there is insufficient evidence for a contribution of hand-transmitted vibration to the development of chronic pain and clinical syndromes in the neck and upper limb, while excessive physical load and ergonomic stress have a primary role in the etiopathogenesis of these disorders.
Collapse
Affiliation(s)
- M Bovenzi
- Unità Clinica Operativa di Medicina del Lavoro, Dipartimento di Scienze di Medicina Pubblica, Università degli Studi di Trieste, Italy.
| | | | | | | |
Collapse
|
28
|
Pappalardo S, Tanteri L, Brutto D, Marescalco M, Carlino V, Consolo G, Mauro M, Cappello V. Mandibular osteomyelitis due to Pseudomonas aeruginosa. Case report. Minerva Stomatol 2008; 57:323-329. [PMID: 18617880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Osteomyelitis is a relatively frequent bacterial infection of the jaw bones. This report describes a case of mandibular osteomyelitis in a surgical site after enucleation of a follicular cyst and extraction of the associated tooth. This case is unusual because maxillary osteomyelitis generally results from polymicrobial infection. In our patient, however, laboratory analysis identified Pseudomonas aeruginosa as the etiologic agent, an opportunistic pathogen normally found on moist surfaces and vegetation. Notorious for its antibiotic multiresistance, P. aeruginosa is increasingly recognized as a serious problem in hospitalized patients. Isolation of the responsible microbe permitted specific antibiotic treatment with a 10-day course of ciprofloxacin (250 mg/12 h), which fully cleared the infection.
Collapse
Affiliation(s)
- S Pappalardo
- Second Section of Dentistry, Department of Medical-Surgical Specialties, Policlinic Hospital Gaspare Rodolico, University of Catania, Catania, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Meyers G, Dunn A, Kovacsovics T, Fleming W, Epner E, Hayes-Lattin B, Mauro M, Deininger M, Bubalo J, Maziarz R. 318: Busulfan, Fludarabine and Total Body Irradiation Followed by Allogeneic Peripheral Blood Stem Cell Transplantation is an Effective Treatment for Hematologic Malignancies with Acceptable Toxicity in a Higher-Risk Population. Biol Blood Marrow Transplant 2008. [DOI: 10.1016/j.bbmt.2007.12.328] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
30
|
Bubalo J, Ciszewski A, Kovascovics T, Meyers G, Mauro M, Epner E, Jones N, Hayes-Lattin B, Deninger M, Curtin P, Leis J, Maziarz R. 269: A Phase II Open Label Pilot Trial of Empiric Daptomycin Treatment for Hematology-Oncology Patients with Febrile Neutropenia (FN). Biol Blood Marrow Transplant 2008. [DOI: 10.1016/j.bbmt.2007.12.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
31
|
Bubalo J, Kovascovics T, Meyers G, Mauro M, Epner E, Hayes-Lattin B, Deininger M, Curtin P, Leis J, Maziarz R. 467: Clonazepam Plus Levetiracetam (CL) for the Prevention of Busulfan-Induced Seizures: A Single Center Experience. Biol Blood Marrow Transplant 2008. [DOI: 10.1016/j.bbmt.2007.12.477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
32
|
Verdu EF, Mauro M, Bourgeois J, Armstrong D. Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis. Can J Gastroenterol 2007; 21:453-5. [PMID: 17637949 PMCID: PMC2657967 DOI: 10.1155/2007/169591] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The present report describes a young woman with no previous gastrointestinal complaints who was initially diagnosed with postinfective irritable bowel syndrome (IBS) after a confirmed case of Campylobacter jejuni enteritis. However, because of persistent diarrhea, new-onset bloating and the development of iron and vitamin deficiencies, serological markers for celiac disease (CD) were evaluated. A positive tissue transglutaminase immunoglobulin A antibody test and repeat endoscopy with duodenal biopsy showing a Marsh IIIa lesion confirmed the diagnosis of CD. Infectious gastroenteritis is a well-established risk factor for the development of IBS, and there is recent evidence that it could play a role in the initiation and exacerbation of inflammatory bowel disease. The present case suggests that the clinical expression of CD can be unmasked by an acute gastrointestinal infection and supports the hypothesis that environmental factors other than gliadin may play a role in the clinical onset of CD in a genetically susceptible host. The increasing availability of serological testing and upper endoscopy has led to increasingly frequent diagnoses of CD and recognition that it may mimic IBS. The present case findings suggest that CD should be considered in the differential diagnosis of persistent IBS-like symptoms after an episode of infectious gastroenteritis.
Collapse
Affiliation(s)
- EF Verdu
- Intestinal Disease Research Program and Division of Gastroenterology, McMaster University, Hamilton, Ontario
| | - M Mauro
- Intestinal Disease Research Program and Division of Gastroenterology, McMaster University, Hamilton, Ontario
| | - J Bourgeois
- Department of Pathology, McMaster University, Hamilton, Ontario
| | - D Armstrong
- Intestinal Disease Research Program and Division of Gastroenterology, McMaster University, Hamilton, Ontario
- Correspondence: Dr David Armstrong, Division of Gastroenterology, Health Sciences Centre – 2F55, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario L8N 3Z5. Telephone 905-521-2100 ext 76404, fax 905-523-6048, e-mail
| |
Collapse
|
33
|
Mauro M, Russello M, Incorvaia C, Gazzola GB, Di Cara G, Frati F. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study. Eur Ann Allergy Clin Immunol 2007; 39:119-22. [PMID: 17523385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
BACKGROUND Sublingual immunotherapy (SLIT) is currently considered a valid option to subcutaneous immunotherapy (SCIT), but only a few studies made a direct comparison of their effectiveness. The aim of this study was to compare the clinical and immunological effects of SCIT and SLIT in pollinosis induced by Betulaceae. METHODS Forty-seven adult patients were randomized to receive SCIT or SLIT, performed by Betulaceae (alder, birch, and hazel) extracts from Stallergenes (Antony, France) standardized in index of reactivity (IR) with the treatment schedules proposed by the producer. The clinical effects were established by symptom-medication scores recorded during the month of March. Side effects were reported directly by the physicians for SCIT and were registered in diary cards by the patients for SLIT. Immunologic evaluation was done by measuring specific IgE and IgG4 to Bet v 1. RESULTS Thirty-four patients (19 for SCIT and 15 for SLIT) completed the registration of symptoms and drug consumption during pollen period of Betulaceae. Mean cumulative doses of respectively 50.65 IR by SCIT and 4653.1 IR by SLIT were administered, with a SLIT/SCIT ratio of 92. There was no significant difference in mean symptom-medication score between SCIT and SLIT. Systemic reactions occurred in 16% of SCIT treated but in none of SLIT treated. As to immunologic evaluation, Bet v 1 specific IgE did not rise after the pollen season in SCIT treated, while increased non significantly in SLIT treated. Bet v 1 specific IgG4 increased in both treatment, buy only the increase with SCIT was significant (p = 0.001). CONCLUSION SLIT and SCIT with a ratio of about 100 are equally effective in controlling rhinoconjunctivitis caused by tree pollen allergy. SLIT is safer than SCIT, but does not show the same immunologic effects on serum specific IgE and lgG4 antibodies.
Collapse
Affiliation(s)
- M Mauro
- Allergy Unit, Sant'Anna Hospital, Como, Italy
| | | | | | | | | | | |
Collapse
|
34
|
Sherbenou DW, Wong MJ, Humayun A, McGreevey LS, Harrell P, Yang R, Mauro M, Heinrich MC, Press RD, Druker BJ, Deininger MW. Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib. Leukemia 2007; 21:489-93. [PMID: 17252009 DOI: 10.1038/sj.leu.2404554] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Residual leukemia is demonstrable by reverse transcriptase-polymerase chain reaction in most patients with chronic myeloid leukemia who obtain a complete cytogenetic response (CCR) to imatinib. In patients who relapse during imatinib therapy, a high rate of mutations in the kinase domain of BCR-ABL have been identified, but the mechanisms underlying disease persistence in patients with a CCR are poorly characterized. To test whether kinase domain mutations are a common mechanism of disease persistence, we studied patients in stable CCR. Mutations were demonstrated in eight of 42 (19%) patients with successful amplification and sequencing of BCR-ABL. Mutation types were those commonly associated with acquired drug resistance. Four patients with mutations had a concomitant rise of BCR-ABL transcript levels, two of whom subsequently relapsed; the remaining four did not have an increase in transcript levels and follow-up samples, when amplifiable, were wild type. BCR-ABL-kinase domain mutations in patients with a stable CCR are infrequent, and their detection does not consistently predict relapse. Alternative mechanisms must be responsible for disease persistence in the majority of patients.
Collapse
MESH Headings
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents/pharmacology
- Antineoplastic Agents/therapeutic use
- Benzamides
- Chromatography, High Pressure Liquid
- Codon/genetics
- DNA Mutational Analysis
- DNA, Neoplasm/genetics
- Drug Resistance, Neoplasm/genetics
- Female
- Follow-Up Studies
- Fusion Proteins, bcr-abl/genetics
- Fusion Proteins, bcr-abl/physiology
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/enzymology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics
- Male
- Middle Aged
- Mutant Proteins/genetics
- Mutant Proteins/physiology
- Mutation
- Piperazines/pharmacology
- Piperazines/therapeutic use
- Protein Kinase Inhibitors/pharmacology
- Protein Kinase Inhibitors/therapeutic use
- Protein Structure, Tertiary/genetics
- Pyrimidines/pharmacology
- Pyrimidines/therapeutic use
- RNA, Messenger/genetics
- RNA, Neoplasm/genetics
- Remission Induction
- Reverse Transcriptase Polymerase Chain Reaction
- Treatment Refusal
Collapse
Affiliation(s)
- D W Sherbenou
- Cell and Developmental Biology, Oregon Health & Science University, Portland, OR 97239, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Pizzocri S, Beltrami L, Rossetti G, Brasca F, Farina A, Mauro M, Pozzi M, Carugo S. Knowledge of Cardiovascular Risk Factors Among European Parliament. High Blood Press Cardiovasc Prev 2007. [DOI: 10.2165/00151642-200714030-00028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
|
36
|
Mauro M, Domenico R, Rutigliano T, Broccolo F, Lusso P. 18: Quantitation of viral DNA in biological fluids: from the bench to the bedside. J Clin Virol 2006. [DOI: 10.1016/s1386-6532(06)70037-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
37
|
Zambon P, Bovo E, Casula A, Gattolin M, Ricci P, Chiosi F, Guzzinati S, Fiore AR, Mauro M. Case Control Study of Soft Tissue Sarcomas in Relation to Dioxin Exposure in the Venice Province. Epidemiology 2006. [DOI: 10.1097/00001648-200611001-01303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Incorvaia C, Sforza GR, Pravettoni C, Mauro M, Puccinelli P, Frati F. Effects of High Dose SLIT on Quality of Life in Patients with Seasonal Asthma. J Allergy Clin Immunol 2006. [DOI: 10.1016/j.jaci.2005.12.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
39
|
Incorvaia C, Senna G, Mauro M, Bonadonna P, Marconi I, Asero R, Nitti F. Prevalence of allergic reactions to Hymenoptera stings in northern Italy. Eur Ann Allergy Clin Immunol 2004; 36:372-4. [PMID: 15662965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
The epidemiology of Hymenoptera venom allergy in Europe showed prevalence of systemic reactions of about 3%, but is scantly investigated in Italy. We studied two samples of the general and an at risk population, i.e. the foresters, in northern Italy. A standardized questionnaire dealing with allergic reactions to Hymenoptera stings was submitted to the subjects included in the study, who were factory workers in Milan and Verona and foresters in Lombardy. An overall number of 574 subjects participated to the study, 462 (299 males and 163 females, mean age 40.1 yrs, range 20-63 yrs) were factory workers and 112 (all males, mean age 38.8 yrs, range 24-59 yrs) were foresters. Among factory workers, 302 (65.4%) were stung by Hymenoptera, 49 (10.6%) had had large local reactions, and 13 (2.8%) systemic reactions. Among foresters, 76 (67.8%) were stung, 11 (9.8%) had had large local reactions, and 5 (4.5%) systemic reactions. The systemic reactions were life-threatening in 3 (0.6%) industrial workers and 2 (1.8%) foresters. The prevalence of systemic reaction of 2.8% in the general population agrees with the data reported from a number of countries with temperate climate. The prevalence of 4.5% in foresters attributed to this population a risk only slightly increased.
Collapse
Affiliation(s)
- C Incorvaia
- Allergy/Rheumatology Unit, ICP Hospital, Milan, Italy
| | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
Hepatopulmonary syndrome--a complication of chronic liver disease-is characterised by hypoxaemia, which results from widespread intrapulmonary vascular dilatations. Amplified production of pulmonary nitric oxide is thought to be important in development of this disorder in patients with liver cirrhosis. Here, we report a 64-year-old man with hepatopulmonary syndrome associated with hepatitis-C-virus-related cirrhosis. We gave the patient nebulised N(G)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthesis, which enhanced oxygenation (arterial oxygen pressure increased from 6.98 to 9.45 kPa). After L-NAME, the distance the patient could walk in 6 min rose by 92 m. Administration of L-NAME by aerosol might offer a new approach to treatment of hepatopulmonary syndrome.
Collapse
Affiliation(s)
- L Brussino
- Department of Medicina e Chirurgia, Ospedale Molinette, Torino, Italy
| | | | | | | | | | | |
Collapse
|
41
|
D'Adamo G, Di Napoli A, Amoroso F, De Martino A, Della Grotta F, Filippini A, Mauro M, Rosa M, Santoboni A, Scaccia F, Di Lallo D, Miceli M, Spinelli C. [Collaborative study on peritoneal dialysis (PD) as first dialysis treatment in an Italian region: 1994-2000]. G Ital Nefrol 2003; 20:381-7. [PMID: 14523899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
BACKGROUND In Lazio, only about 5% of uremic patients are on peritoneal dialysis (PD). The present study focuses on the parameters of PD selection, the treatment schedules, and the clinical outcomes of PD patients in the nine public facilities offering a PD program. A cohort of 249 first-time PD patients, from July 1, 1994 to December 31, 2000, was retrospectively considered. METHODS For the enrollment of the patients, the Regional Dialysis Registry databank was consulted. On December 31, 2000, a systematic review of patient charts was performed to extract the reasons for the PD choice, details of PD schedule, peritonitis episodes, reasons for drop-out, and patient survival rates. In regard to technique success-defined as the probability of having a patient alive on PD-change of modality and death were considered as final events. In regard to patient survival, only death, even in the first 2 months after a shift to hemodialysis, was considered the end point. RESULT The main PD selection reasons were patient and/or nephrologist preference in 90% of cases. One-hundred eighty-nine patients (76%) had been started on CAPD. During the follow-up, 38.2% dialysis schedules had been modified at least once. At the end of follow-up, 41.2% patients were on APD. The peritonitis rate was one episode per 30 patient-months (1 per 27 patient-months in CAPD; 1 per 37 patient-months in APD; p = 0.08). The technique success rate was 66.3% after 2 years and 49.8% after 3 years. The patient survival rate was 81.1% after 2 years and 68.7% after 3 years. CONCLUSIONS Patients chose PD as a first dialysis treatment mainly because of reasons unrelated to their clinical status. The technique's success, patient mortality rates, and the peritonitis rate do not explain the low PD diffusion in the region. The peritonitis rate meets the target criteria for excellence recommended by the Italian Society of Nephrology. The observed outcomes may have been favored by the selection of motivated patients and by the increased use of APD.
Collapse
Affiliation(s)
- G D'Adamo
- U.O.C. Nefrologia e Dialisi, Ospedale S. Spirito, Roma.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Mastrogiacomo AR, Ottaviani MF, Pierini E, Cangiotti M, Mauro M, Mangani F. Comparison of chemical and physical properties of carbon blacks for sampling and analysis of environmental pollutants. Chromatographia 2002. [DOI: 10.1007/bf02491670] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
43
|
Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci Appl 2001; 756:11-7. [PMID: 11419701 DOI: 10.1016/s0378-4347(01)00067-6] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To evaluate incidence and causes of anaphylactic reactions in the emergency room (E.R.) of a general hospital in Milan during a 2-year period. METHODS We retrospectively studied the computerized records of patients discharged from an E.R. with a diagnosis of anaphylactic reaction. Anaphylaxis was established on the presence of at least two cutaneous, respiratory, gastrointestinal or cardiovascular system symptoms. RESULTS During 1997 and 1998, out of 38 685 patients referred to the E.R., 13 had severe anaphylaxis with loss of consciousness (LOC) and 127 had anaphylactic symptoms, without LOC. Of the 13 patients with LOC, a possible cause was identified in 12 (five foods, six drugs, one hair dye). In the other 127 patients anaphylaxis was related to foods in 49 cases (38.5%), drugs in 44 (34.6%), unknown causes in 29 (22.8%), hymenoptera stings in two (1.5%), and other causes in three (2.3%). CONCLUSION The incidence of anaphylactic reactions was 0.4% and mainly affected females and atopic subjects. Foods, particularly fruits and vegetables, appeared to be the most important cause; other important causes were non steroidal antiinflammatory drugs and beta-lactam antibiotics.
Collapse
Affiliation(s)
- E A Pastorello
- 3rd Division of General Medicine, Ospedale Maggiore, IRCCS, Milan, Italy.
| | | | | | | | | |
Collapse
|
44
|
Mauro M, Kim J, Costello C, Laurence J. Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. Am J Hematol 2001; 66:12-22. [PMID: 11426486 DOI: 10.1002/1096-8652(200101)66:1<12::aid-ajh1001>3.0.co;2-i] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Primary human microvascular endothelial cells (MVEC) of restricted lineage undergo apoptosis when exposed to plasma from patients with thrombotic thrombocytopenic purpura (TTP) and sporadic hemolytic-uremic syndrome (HUS). This reflects the pathology and tissue distribution of lesions in vivo. As extracellular matrix (ECM) is critical to MVEC survival, and cytokines which regulate ECM, such as transforming growth factor (TGF)-beta1, have been reported anecdotally to be altered in TTP/HUS, we examined the role of TGF-beta1 and two ECM proteins, fibronectin and thrombospondin (TSP), in these disorders. Levels of active TGF-beta1 were elevated in acute but not convalescent phases of TTP/sporadic HUS, as well as TTP associated with human immunodeficiency virus infection and use of the anti-platelet drug ticlopidine. MVEC from tissues susceptible to TTP-mediated apoptosis showed little active TGF-beta1 production when exposed to TTP plasmas. In contrast, pulmonary MVEC and large-vessel EC, which are resistant to TTP-linked pathology, showed marked induction of TGF-beta1 following TTP plasma exposure. Exogenous TGF-beta1 suppressed TTP plasma-mediated apoptosis in susceptible MVEC in association with blockade of cell entry into S phase. Soluble TSP, devoid of detectable bound TGF-beta1, had a similar effect, which paralleled its ability to induce TGF-beta1 production in MVEC. In vivo, TSP deposition was diminished markedly in involved tissues of TTP patients. These data highlight the role of TGF-beta1 and ECM in TTP and suggest that differential production of TGF-beta1 by MVEC may play a role in their sensitivity or resistance to TTP/sporadic HUS-mediated apoptosis in vitro and in vivo.
Collapse
Affiliation(s)
- M Mauro
- Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
| | | | | | | |
Collapse
|
45
|
Valat L, Toutain S, Courtois N, Gaire F, Decout E, Pinck L, Mauro M, Burrus M. GFLV replication in electroporated grapevine protoplasts. Plant Sci 2000; 155:203-212. [PMID: 10814824 DOI: 10.1016/s0168-9452(00)00220-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Grapevine fanleaf virus (GFLV), responsible for the economically important court-noué disease, is exclusively transmitted to its natural host in the vineyards through Xiphinema nematodes. We have developed direct inoculation of GFLV into grapevine through protoplast electroporation. Protoplasts were isolated from mesophyll of in vitro-grown plants and from embryogenic cell suspensions. Permeation conditions were determined by monitoring calcein uptake. Low salt poration medium was selected. Electrical conditions leading to strong transient gene expression were also tested for GFLV inoculation (isolate F13). GFLV replication was detected with either virus particles (2 µg) or viral RNA (10 ng) in both protoplast populations, as shown by anti-P38 Western blotting. Direct inoculation and replication were also observed with Arabis mosaic virus (ArMV), a closely related nepovirus, as well as with another GFLV isolate. These results will be valuable in grapevine biotechnology, for GFLV replication studies, transgenic plant screening for GFLV resistance, and biorisk evaluation.
Collapse
Affiliation(s)
- L Valat
- Laboratoire de Biologie et Physiologie Végétales (URVVC, UPRES EA 2069), URCA, BP1039, F-51687, Reims, France
| | | | | | | | | | | | | | | |
Collapse
|
46
|
|
47
|
Affiliation(s)
- C Incorvaia
- Ospedale Policlinico, Padiglione Granelli, Milan, Italy
| | | | | |
Collapse
|
48
|
Amato A, Saccomani G, Mauro M, Gramegna A. [Extended lymphadenectomy in carcinoma of the right colon]. G Chir 1997; 18:272-6. [PMID: 9312254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The Authors report on a retrospective study concerning 49 patients treated for a modified Dukes' stage B, C or D right colon cancer. A potentially curative right hemicolectomy with extended lymphadenectomy was performed. Locally advanced disease was treated by "en bloc" resection. Two (4.1%) patients died after surgery, in other 2 (4.1%) cases major postoperative complications were registered. Microscopic examination of the surgical specimens showed lymph node metastases in 44.9% of the cases: in this subgroup a metastatic involvement of the main (III level) nodal groups was detected in 22.7% of the patients. The Authors conclude that extended lymph node dissection does not increase postoperative complications and may play a role in the treatment of right colon cancer. A not negligible group of patients may be understaged or receive inadequate surgical treatment when submitted to traditional right colectomy.
Collapse
Affiliation(s)
- A Amato
- Dipartimento di Gastroenterologia, Presidio Ospedaliero di Sanremo (IM)
| | | | | | | |
Collapse
|
49
|
Frairia R, Fortunati N, Fazzari A, Fissore F, Comba A, Becchis M, Catalano MG, Benedusi-Pagliano E, Berta L, Mauro M, Gaidano G. Sex steroid binding protein is a negative modulator of estrogen-induced breast cancer cell growth. Ann N Y Acad Sci 1996; 784:362-9. [PMID: 8651584 DOI: 10.1111/j.1749-6632.1996.tb16250.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- R Frairia
- Dipartimento di Fisiopatologia Clinica, University of Turin Medical School, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Gallucci M, Puppo P, Fortunato P, Mauro M, Vincenzoni A, Zaccara A. Transurethral electrovaporization of the prostate with the Vaportrode VE-B. Preliminary results. Eur Urol 1996; 29:450-5. [PMID: 8791053 DOI: 10.1159/000473795] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
UNLABELLED Transurethral resection of the prostate (TURP) is still considered the 'gold standard' in the treatment of benign prostatic hyperplasia (BPH). However, it is possible to replace this technique in particular situations (advanced age, serious cardiovascular, respiratory and metabolic disorders). OBJECTIVE The aim of this study is to propose an alternative treatment to TURP with a minimal invasiveness, rapid discharge of the patient and lower costs achieving the same results as TURP. We have used electrovaporization of the prostatic tissue to investigate the outcome of electrovaporization in the treatment of patients with BPH. METHODS A grooved rolling electrode with a large surface contact was used (Vaportrode VE-B; Circon Acmi, USA), mounted on a common resectoscope connected to a normal high-frequency discharge unit. This concentration of high energy produces an area of high current density at the point of contact with the prostatic tissue and a consequent thermal reaction which causes the tissue temperature to rise rapidly until vaporization. In the period ranging from January 1995 to June 1995, 35 patients with BPH were treated. RESULTS The average maximal flow increased from 9.8 +/- 3.18 to 13.6 +/- 5.9 ml/s at 2 days and to 20.74 +/- 9.8 ml/s at 28 days (p < or = 0.01); the average symptom score decreased from 18.17 +/- 4.5 to 10.4 +/- 3.3, 28 days after surgery with an average improvement of 52% (p < or = 0.01). Voiding pressure at 28 days was 22.9 +/- 2 cm H2O (p < or = 0.01). Sixteen patients were obstructed preoperatively while 19 patients were unobstructed postoperatively and 3 were equivocal as shown in the Abrams-Griffiths nomogram. Postvoiding residual urine was 0 ml at the follow-up at 2 and 28 days. The average reduction in weight of the prostatic adenoma, measured with transrectal ultrasound and the ellipsoid formula, was 84% (range 50-90%). CONCLUSION We think that this technique represents an interesting alternative in the treatment of symptomatic BPH.
Collapse
Affiliation(s)
- M Gallucci
- Department of Urology, Cristo Re Hospital, Rome, Italy
| | | | | | | | | | | |
Collapse
|